Model
Edge
Revance Therapeutics Inc.
0001678984
Filing Type
144
Filing Date
3/17/2024
Updated
3/18/24, 12:13 AM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities